Feb. 17 at 2:44 PM
$TMCI Treace Medical Concepts develops Lapiplasty 3D bunion correction systems with
$209M revenue but persistent losses, trading at
$1.86 near 52-week lows after an 81% market cap decline, with analysts setting a
$4.21 price target .